Study title: Double-blind, randomized, placebo-controlled trial of the efficacy and safety of 5% minoxidil foam in the treatment of androgenetic alopecia in males
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
| Brands: | |||||
| MAH holders: | |||||
| Assessment: | |||||
| Active substance: MINOXIDIL | |||||
| ATC code: | |||||
| Document link: minoxidil A6221001.pdf | |||||
| Document date: 2011-09-28 | |||||
| Study number: Protocol A6221001 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |